Bain Capital to Acquire Vitabiotics, Plans to Accelerate Global Growth of the UK Vitamin Brand

Bain Capital Signs Agreement to Acquire Vitabiotics

Bain Capital, a global private investment firm, has announced that it has entered into an agreement to acquire Vitabiotics, the UK's number one vitamin company.

The acquisition includes Vitabiotics' UK operations as well as the wider VB Group, which includes Meyer Organics in India and the company's operations across Africa, including VB Egypt.

The deal marks a major milestone in Vitabiotics' 55-year history and is expected to support the company's next stage of international growth and business expansion.

Partnership Aims to Expand Vitabiotics Worldwide

The transaction brings together one of the world's leading healthcare and consumer-focused investment firms with one of the best-known independent vitamins, minerals, and supplements companies.

Both companies expect the partnership to create new opportunities for global expansion while strengthening Vitabiotics' position in existing markets.

According to the companies, the focus will be on growing internationally while continuing to build trusted health and wellness brands.

UK Operations Will Continue Without Immediate Changes

Vitabiotics said there will be no immediate changes to its day-to-day operations following the acquisition.

The United Kingdom will continue to remain the company's center for brand development, product innovation, and category leadership.

The company also plans to continue serving customers, healthcare professionals, and business partners while investing in several growth areas, including:

• Digital capabilities
• E-commerce
• International distribution
• Supply chain resilience
• New product development

These investments are expected to strengthen the company's long-term global presence.

Bain Capital to Support Expansion Across Key Markets

Given Vitabiotics' strong international business, the investment will be led by Bain Capital's Asia Private Equity team with support from the firm's global investment platform.

Bain Capital plans to use its experience in healthcare, consumer products, and international markets to help Vitabiotics expand further.

The company will also provide local market expertise in India while supporting future growth across important regions, including:

• India
• Middle East and North Africa (MENA)
• China
• Africa

The goal is to strengthen Vitabiotics' international operations and increase the reach of its products.

A Company Built on Science and Innovation

Vitabiotics was founded in 1971 by Professor Kartar Lalvani OBE, who introduced science-based nutritional supplements and helped establish the nutraceutical industry.

Over the years, the company developed several vitamin and supplement categories focused on different health conditions and life stages.

Today, Vitabiotics is widely recognized for combining scientific research with consumer health products.

Leadership Helped Drive International Growth

During the past decade, the company has expanded significantly under the leadership of Group Chief Executive Officer Tej Lalvani.

Having worked in the business for more than 30 years, Tej Lalvani has played a key role in transforming Vitabiotics from a family-owned British business into a globally recognized nutraceutical company.

The company has expanded through product innovation, strategic partnerships, and international market growth.

Outside the business, Tej Lalvani is also well known in the UK as an entrepreneur and investor through his role on the BBC television program Dragons' Den.

Following completion of the transaction, company founder Professor Kartar Lalvani will become Chairman Emeritus in recognition of his long contribution to the business.

Professor Ajit Lalvani, who has served as a non-executive director while pursuing a distinguished academic and clinical career, has also contributed scientific and medical expertise to the company for more than three decades.

Strong Presence Across Global Markets

Vitabiotics has built a strong business across several major vitamins and supplements markets around the world.

Besides being the leading vitamin company in the United Kingdom, the company has established a growing presence in:

• India
• China
• Egypt
• Middle East and North Africa

Its growth has been supported by consumer trust, healthcare professional recommendations, and local market expertise.

Portfolio Includes Well-Known Supplement Brands

Vitabiotics markets several popular vitamin and nutritional supplement brands across different health categories.

Its portfolio includes products such as:

• Pregnacare
• Perfectil
• Wellman
• Wellwoman
• Osteocare
• Ultra range

These brands are widely recognized by consumers and healthcare professionals in multiple countries.

Company Sees New Opportunities with Bain Capital

Tej Lalvani described the agreement as an important milestone in the company's journey.

He said the partnership is intended to accelerate Vitabiotics' international expansion while maintaining the company's long-standing commitment to science, quality, and innovation.

According to him, Bain Capital's global experience will help the company bring its products to millions of additional consumers around the world while supporting future product innovation.

Bain Capital Highlights Growth Potential

Pawan Singh, Partner at Bain Capital, said Vitabiotics represents the type of science-led healthcare business the investment firm looks to support.

He noted the company's leadership in the vitamin, mineral, and supplement category along with its strong presence across the UK, India, the Middle East, Africa, and China.

He added that Bain Capital's India team has significant experience working with healthcare and consumer companies and looks forward to supporting Vitabiotics' next stage of growth.

Rishi Mandawat, also a Partner at Bain Capital, said the company sees significant opportunities to build on Vitabiotics' leadership in the UK while strengthening its international business.

He said Bain Capital plans to contribute sector expertise, operational resources, and local market knowledge to support investments in innovation, international distribution, e-commerce, and business operations.

Bain Capital Continues Healthcare Investments

Founded in 1984, Bain Capital is one of the world's leading private investment firms with investments across multiple industries.

The acquisition of Vitabiotics reflects Bain Capital's continued interest in healthcare, nutrition, and consumer wellness businesses, while supporting companies with strong brands and long-term international growth potential.